A Novel Ruthenium-Fluvastatin Complex Downregulates SNCG Expression to Modulate Breast Carcinoma Cell Proliferation and Apoptosis via Activating the PI3K/Akt/mTOR/VEGF/MMP9 Pathway

Breast cancer is the most common cause of malignancy and cancer-related morbidity and death worldwide that requests effective and safe chemotherapy. Evaluation of metallodrug-based anticancer agents and statins as chemotherapeutics with fewer side effects is a largely unexplored research field. Synt...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wei, Shi, Junfeng, Xia, Haiyan, Wei, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221895/
https://www.ncbi.nlm.nih.gov/pubmed/34221232
http://dx.doi.org/10.1155/2021/5537737

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221895/
https://www.ncbi.nlm.nih.gov/pubmed/34221232
http://dx.doi.org/10.1155/2021/5537737

Ejemplares similares